A study undertaken to evaluate the efficacy and tolerability of single pulse transcranial magnetic stimulation (sTMS) for the preventive treatment of migraine has led to an FDA extended indication.
This Week on NeurologyLive® — July 22, 2024
Sleeping Around the Podcast × NeurologyLive: Calcitonin Gene-Related Peptide in Sleep Research
Updates in Therapeutic Development: Clinical Trial Readouts to Watch in the Second Half of 2024
Episode 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings
This Week on NeurologyLive® — July 15, 2024
NeurologyLive® Brain Games: July 14, 2024